Introduction: We report a case of a seemingly typical presentation of giant cell arteritis (GCA) with lack of response to steroid therapy which was, in fact, found to be due to underlying infection with syphilis causing a clinical syndrome with symptoms which mimicked GCA. Treatment of the infection led to complete resolution of the symptoms. Whilst syphilis is known to cause a wide range of multi-systemic symptoms, it is not usually considered in the different diagnosis in patients presenting with symptoms suggestive of GCA, as evidenced by the scarcity of previously documentedcases. Case description: A 64 year old male was referred to the infectious disease team by his GP with an eight-week history of drenching, intermittent night sweats, weight loss and low-grade raised inflammatory markers (CRP 37 mg/L, ESR 44 mm/hr). Screening for HIV and viral hepatitis was negative and there was no personal or contact history of TB nor any evidence of infectious or tropical disease. Autoantibody screen had been performed and ANA was found to be weakly positive at 1/100 but ENA, rheumatoid factor, anti-CCP and ANCA were all negative. CT of chest, abdomen and pelvis was normal however the patient subsequently reported a new-onset generalised headache. Inflammatory markers remained raised. On further detailed questioning, the patient reported some recent aching of the proximal upper limbs. He was hence referred for rheumatology opinion. Three weeks later, the patient presented to the emergency department with severe unilateral temporal headache, a sensation of burning of the scalp, hair loss and some visual blurring. Examination revealed a tender, thickened and hyperaesthetic temporal artery. Inflammatory markers remained elevated with ESR 32 mm/hr and CRP 20 mg/L. The impression was of PMR evolving into GCA and the patient was commenced on 60 mg daily of prednisolone. The patient was reviewed six days later and reported an improvement of his symptoms and a plan was made for weaning of the steroids. Temporal artery biopsy was performed and showed no evidence of temporal arteritis. One month later, the patient requested an urgent review due to a relapse of all of his symptoms. On this occasion, the patient was particularly concerned about worsening alopecia and more severe bilateral shoulder aching. Inflammatory markers remained at similar levels to those previous. His prednisolone was increased again and, it was thought his steroids had beenweaned toorapidly. He wasalsoreferred todermatology foranopinion regarding his hair loss. During the same period, the patient's wife was referred to the genitourinary clinic for infective symptoms and the patient was subsequently requested for testing as a potential contact. It was noted in the sexual health clinic that the patient had additionally developed a mildly pruritic, faint, papular rash on both palms. Treponema pallidum particle assay (TPPA) was positive with a rapid plasma regain (RPR) titre of 1: 32. Secondary syphilis was confirmed and the patient was subsequently treated with intramuscular penicillin-G. Within two weeks, the patient reported rapid resolution of all his symptoms including the rash, hairloss,headache, scalp tenderness andshoulderpain.CRP wasmeasured at 4 mg/L and ESR was 14 mm/hr. At the following clinic review, the patient had regained weight and steroids were tapered. The patient remained well at subsequent follow up (CRP <1, ESR 2) and continued to remain asymptomatic on no steroid therapy. One year on, he remains well with no recurrence of hissymptoms. Discussion: Syphilis has long been known as the great mimicker for its ability to present in a wide range of symptoms affecting multiple systems. Secondary syphilis represents haematogenous dissemination from the initial site of infection (as sometimes represented by a primary chancre) and most commonly presents with skin rashes, alopecia and lymphadenopathy. Late or tertiary syphilis often occurs two or more years after acquisition and causes gumma formation, aortitis and neurological involvement such as focal arteritis causing infarction and meningeal inflammation. This case represents a rare case of secondary syphilis presenting initially with symptoms highly suggestive of classic giant cell arteritis. Only two previous such cases have been reported in the literature. Such was the clear constellation of symptoms, the patient was treated with high dose oral steroids as is common practice but tellingly failed to respond accordingly and, indeed, subsequently experienced a worsening of symptoms. The only initial clue regarding the atypical nature of this case, prior to the later development of the palmar rash, was the prominent alopecia which is described in secondary syphilis. Tertiary neurosyphilis with meningeal involvement is rare but would present with additional neurological symptoms such a seizure or cranial nerve palsy. The mechanism behind secondary infection causing headache and a mimicking of giant cell arteritis is unclear and a negative temporal artery biopsy would not include or exclude the condition regardless. Whilst an extremely rare manifestation, this case is interesting in being a reminder that other systemic infections can often present similarly to inflammatory conditions seen within rheumatology. Secondary syphilis should be considered within the differential diagnosis of patients presenting with symptoms suggestive of GCA, especially in atypical cases or when there is a lack of response to steroid therapy. Key Learning Points: Include multi-systemic infection within the differential for patients presenting with symptoms consistent with inflammatory of or connective tissue disease. Exclude other causes when giant cell arteritis remains unresponsive to conventionaltreatment. Disclosure: S. Black: None. C. Raine: None. D. Ivens: None. R. Stratton: None. Introduction: Systemic lupus erythematosus (SLE) can be associated with various neuropsychiatric manifestations affecting the nervous system at multiple levels, with differing neuropathology. Among them, transverse myelitis is one of the rare neurologic syndromes that can present with the rapid onset of weakness, sensory alterations and bowel, bladder or sexual dysfunction. This syndrome is thought to be due to an arteritis, with resultant ischemic necrosis of the spinal cord, which has been associated with anti phospholipid antibodies (aPL) insomestudies. Case description: A 30 year old female with quiescent SLE on hydroxychloroquine 200 mg/400 mg alternate days, had been diagnosed in 2010 with features characterised by fatigue, arthralgias, a short-lived malar rash, resolved low level proteinuria, ANA and anti-Ro positivity. She presented in 2015 with an eight-week fluctuating history of sudden onset significant pain in her neck, which radiated into her shoulders bilaterally associated with some tingling down the medial aspect of both arms into the medial two digits. She also reported some decline in dexterity in both hands with bilateral weak finger grip worse on the left side as well as frequent headaches. However, there was no symptomatic evidence of sphincter or lower limb dysfunction at that time. Cranial nerve examination including fundoscopy was normal. On assessment of co-ordination, however, she had as a subtle action and postural tremor of left arm. In addition, there was mild weakness distally in the hands worse on the left side, particularly in finger extension and finger abduction. Of note, her reflexes were present and symmetrical. MRI imaging of the head was normal. MRI of the spine and subsequent gadolinium enhanced imaging demonstrated an area of expansion of the upper thoracic cord from T1 to T3, with features of generalised oedema of the cord and intramedullary signal change between C7 and T3. Specialist neuroradiological review suggested that this was more in keeping with transverse myelitis than a neoplasm. What is more, lumbar puncture showed raised CSF protein (0.83g/L), no organisms on culture or PCR and no malignant cells. She was treated with oral methylprednisolone 250 mg twice daily for five days with bone and gastric protection followed by daily prednisolone reducing dose. She received high dose IV cyclophosphamide (15 mg/kg) for as she continued to have progressive neurological symptoms with lower limb weakness. Following completion of six pulses of IV cyclophosphamide, she was maintained on azathioprine until the end of 2017. Serial MRI imaging of her thoracic and lumbar spine showed no evidence of further progression fortunately. Overtime with neurorehabilitation, this patient has made a good recovery and has not had any further SLE activity. She has had corticosteroid induced side-effects and became very cushingoid, which has improved off treatment. She continues just on hydroxychloroquine treatment. Discussion: Although clinical presentation and MRI imaging features are most suggestive of a transverse myelitis, alternative possibilities such as a focal syrinx, space occupying lesion and multiple sclerosis were considered and ultimately excluded on the serial imaging and clinical progress. Biopsy was not considered a possible or safe option. Although usually a late manifestation of SLE, transverse myelitis can occur at presentation. Interestingly, a longitudinally extensive transverse myelitis has been reported as a phenomenon purely related to underlying SLE but is most commonly seen in neuromyelitis optica or NMO-spectrum disorders which occur in higher frequency in patients who also suffer from SLE. Therefore, it is helpful to perform gadolinium-enhanced MRI spine and antibody profile for neuromyelitis optica spectrum disorders. A sensory level with spastic lower limb weakness and sphincter disturbance is usually the most common presentation, but a thoracic or cervical sensory i12 September 2018 CASE REPORTS
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